On June 18, 2026, OpenAI said it had published a study in NEJM AI, conducted with researchers at Boston Children's Hospital and Harvard, in which its o3 reasoning model helped clinicians revisit long-unsolved rare pediatric disease cases and reach new diagnoses.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.